Capital Management’s AbbVie ABBV Stock Holding History

Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$258K	Hold	1,026	–	–	0.04%	63
2026 Q1	$223K	Hold	1,026	–	–	0.04%	66
2025 Q4	$234K	Hold	1,026	–	–	0.04%	67
2025 Q3	$238K	Buy	+1,026	New	+$209K	0.04%	69
2025 Q2	–	Sell	-1,056	Closed	-$221K	–	81
2025 Q1	$221K	Buy	+1,056	New	+$205K	0.04%	72
2024 Q4	–	Sell	-1,086	Closed	-$215K	–	78
2024 Q3	$215K	Buy	+1,086	New	+$203K	0.04%	76
2024 Q2	–	Sell	-1,235	Closed	-$225K	–	76
2024 Q1	$225K	Buy	+1,235	New	+$213K	0.04%	74
2018 Q3	–	Sell	-2,772	Closed	-$257K	–	85
2018 Q2	$257K	Hold	2,772	–	–	0.07%	65
2018 Q1	$262K	Sell	2,772 -500	-15%	-$54.9K	0.07%	73
2017 Q4	$316K	Hold	3,272	–	–	0.09%	67
2017 Q3	$291K	Hold	3,272	–	–	0.08%	68
2017 Q2	$237K	Hold	3,272	–	–	0.07%	82
2017 Q1	$213K	Buy	+3,272	New	+$206K	0.07%	91
2015 Q1	–	Sell	-3,337	Closed	-$218K	–	82
2014 Q4	$218K	Buy	+3,337	New	+$210K	0.07%	80

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital Management's ABBV Position: Q2 2026 in Review

Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,026 shares worth $258K. The position accounts for 0.04% of the portfolio, ranked #63.

Capital Management first reported a position in ABBV in Q4 2014 and has held it in 14 quarters since. The position peaked at $316K in Q4 2017. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Capital Management held 1,026 shares of AbbVie worth $258K as of Q2 2026.
Capital Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.04% of Capital Management's portfolio in Q2 2026, its #63 holding.
Capital Management first reported a position in AbbVie in Q4 2014 and has held it in 14 quarters since.
Capital Management's AbbVie position peaked at $316K in Q4 2017.
4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.